Prostate Cancer Theranosis: 68Ga PSMA PET/CT and 177Lu PSMA Therapy
The AJR Lecture Series brings presentations on the most important AJR articles to your desktop, available for viewing at home or office and on your schedule. This Lecture has an estimated time to complete the activity of 1 hour.
Target Audience:
The target audience for this activity is radiologists at all training levels with an interest in nuclear medicine and PET-CT in prostate cancer detection, staging, and recurrence.
Goals and Objectives:
After completing the material in this article, the learner should be able to:
- Articulate the value of 68Ga PSMA PET/CT in imaging prostate cancer detection, staging, and recurrence; and
- Discuss the value and impact of 177Lu PSMA therapy in treating prostate cancer patients.
Disclosure of Commercial Interest:
- RM Subramaniam was a principal investigator for the 177Lu-DOTATATE expanded access program supported by Advanced Accelerator Applications, a Novartis company, and is a principal investigator for clinical trials sponsored by Endocyte Inc. and GE Healthcare
- AT Kendi is a principal investigator in a clinical trial supported by Endocyte Inc
Member Price:
Free
NonMember Price:
$250.00
Accreditation Statement
The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
Designation Statement
The ARRS designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit(s)™.
Date of issuance: August 23, 2019
Date of expiration: August 22, 2022
Estimated time to complete the activity: 1 hour(s)
The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
Designation Statement
The ARRS designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit(s)™.
The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The ARRS designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)™ and 1 American Board of Radiology©, MOC Part II, Self-Assessment CME (SA-CME.) Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Date of issuance: August 23, 2019
Date of expiration: August 22, 2022
Estimated time to complete the activity: 1 hour(s)